References
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for the diagnosis, management, and prevention of COPD Available from: http://goldcopd.org/Accessed June 7, 2016
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- MohanAChandraSAgarwalDPrevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic reviewRespirology201015353654220415983
- SethiSMurphyTFInfection in the pathogenesis and course of chronic obstructive pulmonary diseaseN Engl J Med2008359222355236519038881
- RoedeBMBresserPPrinsJMSchellevisFVerheijTJBindelsPJReduced risk of next exacerbation and mortality associated with antibiotic use in COPDEur Respir J200933228228819047316
- AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
- BruntonSCarmichaelBPColganRAcute exacerbation of chronic bronchitis: a primary care consensus guidelineAm J Manag Care2004101068969615521160
- SethiSInfectious etiology of acute exacerbations of chronic bronchitisChest20001175 Suppl 2380S385S10843981
- EchevarriaCSteerJHeslop-MarshallKValidation of the DECAF score to predict hospital mortality in acute exacerbations of COPDThorax201671213314026769015
- SteerJGibsonJBourkeSCThe DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary diseaseThorax2012671197097622895999
- AssicotMGendrelDCarsinHRaymondJGuilbaudJBohuonCHigh serum procalcitonin concentrations in patients with sepsis and infectionLancet199334188445155188094770
- BafadhelMClarkTWReidCProcalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPDChest201113961410141821030489
- CrisafulliEMenéndezRHuertaASystemic inflammatory pattern of patients with community-acquired pneumonia with and without COPDChest201314341009101723187314
- HuertaACrisafulliEMenéndezRPneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristicsChest201314441134114223828375
- KoutsokeraAStolzDLoukidesSKostikasKSystemic biomarkers in exacerbations of COPD: the evolving clinical challengeChest2012141239640521835899
- BrielMSchuetzPMuellerBProcalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary careArch Intern Med20081681820002007 discussion 2007–200818852401
- DaubinCParientiJJVabretAProcalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort studyBMC Infect Dis2008814518947382
- StolzDChrist-CrainMMorgenthalerNGCopeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPDChest200713141058106717426210
- PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med2006173101114112116484677
- SethiSMolecular diagnosis of respiratory tract infection in acute exacerbations of chronic obstructive pulmonary diseaseClin Infect Dis201152Suppl 4S290S29521460287
- HuiDSIpMLingTA multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitisRespirology201116353253921299688
- SethiSSethiREschbergerKAirway bacterial concentrations and exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007176435636117478618
- CameronRJde WitDWelshTNFergusonJGrissellTVRyePJVirus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilationIntensive Care Med20063271022102916791664
- ChenHWangDBaiCWangXProteomics-based biomarkers in chronic obstructive pulmonary diseaseJ Proteome Res2010962798280820387909
- RammaertBVerdierNCavestriBNseirSProcalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary diseaseRespirology200914796997419659517
- MüllerBHarbarthSStolzDDiagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumoniaBMC Infect Dis200771017335562
- WeisNAlmdalTC-reactive protein – can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease?Eur J Intern Med2006172889116490683
- WangYStavemKDahlFAHumerfeltSHaugenTFactors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD)Int J Chron Obstruct Pulmon Dis201499910524477272
- AgboadoGPetersJDonkinLFactors influencing the length of hospital stay among patients resident in Blackpool admitted with COPD: a cross-sectional studyBMJ Open201225e000869
- SchuetzPChrist-CrainMThomannRProHOSP Study GroupEffect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trialJAMA2009302101059106619738090
- SchuetzPAlbrichWMuellerBProcalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and futureBMC Med2011910721936959
- KheradOKaiserLBridevauxPOUpper viral respiratory infection, biomarkers and COPD exacerbationsChest2010138489690420435659
- SeemungalTHarper-OwenRBhowmikARespiratory viruses,symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116491618162311719299
- WilkinsonTMHurstJRPereraWRWilksMDonaldsonGCWedzichaJAEffect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPDChest2006129231732416478847
- LacomaAPratCAndreoFValue of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011615716921468168
- ChenYWLeungJMSinDDA systematic review of diagnostic biomarkers of COPD exacerbationPLoS One2016117e015884327434033